Literature DB >> 27771387

HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes.

Dulce Alfaiate1, Julie Lucifora2, Natali Abeywickrama-Samarakoon1, Maud Michelet1, Barbara Testoni1, Jean-Claude Cortay1, Camille Sureau3, Fabien Zoulim4, Paul Dény5, David Durantel6.   

Abstract

Hepatitis D virus (HDV) super-infection of Hepatitis B virus (HBV)-infected patients is the most aggressive form of viral hepatitis. HDV infection is not susceptible to direct anti-HBV drugs, and only suboptimal antiviral responses are obtained with interferon (IFN)-alpha-based therapy. To get insights on HDV replication and interplay with HBV in physiologically relevant hepatocytes, differentiated HepaRG (dHepaRG) cells, previously infected or not with HBV, were infected with HDV, and viral markers were extensively analyzed. Innate and IFN responses to HDV were monitored by measuring pro-inflammatory and interferon-stimulated gene (ISG) expression. Both mono- and super-infected dHepaRG cells supported a strong HDV intracellular replication, which was accompanied by a strong secretion of infectious HDV virions only in the super-infection setting and despite the low number of co-infected cells. Upon HDV super-infection, HBV replication markers including HBeAg, total HBV-DNA and pregenomic RNA were significantly decreased, confirming the interference of HDV on HBV. Yet, no decrease of circular covalently closed HBV DNA (cccDNA) and HBsAg levels was evidenced. At the peak of HDV-RNA accumulation and onset of interference on HBV replication, a strong type-I IFN response was observed, with interferon stimulated genes, RSAD2 (Viperin) and IFI78 (MxA) being highly induced. We established a cellular model to characterize in more detail the direct interference of HBV and HDV, and the indirect interplay between the two viruses via innate immune responses. This model will be instrumental to assess molecular and immunological mechanisms of this viral interference. Copyright Â
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hepatitis B virus; Hepatitis D virus; IFN response; Interferon stimulated genes; Viral interference

Mesh:

Substances:

Year:  2016        PMID: 27771387     DOI: 10.1016/j.antiviral.2016.10.006

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  27 in total

1.  Hepatitis B Virus DNA Integration Occurs Early in the Viral Life Cycle in an In Vitro Infection Model via Sodium Taurocholate Cotransporting Polypeptide-Dependent Uptake of Enveloped Virus Particles.

Authors:  Thomas Tu; Magdalena A Budzinska; Florian W R Vondran; Nicholas A Shackel; Stephan Urban
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

2.  Interaction between Toll-Like Receptor 9-CpG Oligodeoxynucleotides and Hepatitis B Virus Virions Leads to Entry Inhibition in Hepatocytes and Reduction of Alpha Interferon Production by Plasmacytoid Dendritic Cells.

Authors:  Ludovic Aillot; Marc Bonnin; Malika Ait-Goughoulte; Nathalie Bendriss-Vermare; Sarah Maadadi; Laura Dimier; Miroslava Subic; Caroline Scholtes; Isabel Najera; Fabien Zoulim; Julie Lucifora; David Durantel
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

Review 3.  Modulators of innate immunity as novel therapeutics for treatment of chronic hepatitis B.

Authors:  Aleksei Suslov; Stefan Wieland; Stephan Menne
Journal:  Curr Opin Virol       Date:  2018-02-20       Impact factor: 7.090

4.  N6-Methyladenine Modification of Hepatitis Delta Virus Regulates Its Virion Assembly by Recruiting YTHDF1.

Authors:  Geon-Woo Kim; Jae-Su Moon; Severin O Gudima; Aleem Siddiqui
Journal:  J Virol       Date:  2022-09-14       Impact factor: 6.549

Review 5.  Genomics of Viral Hepatitis-Associated Liver Tumors.

Authors:  Camille Péneau; Jessica Zucman-Rossi; Jean-Charles Nault
Journal:  J Clin Med       Date:  2021-04-22       Impact factor: 4.241

6.  AAV-HDV: An Attractive Platform for the In Vivo Study of HDV Biology and the Mechanism of Disease Pathogenesis.

Authors:  Sheila Maestro; Nahia Gómez-Echarte; Gracián Camps; Carla Usai; Lester Suárez; África Vales; Cristina Olagüe; Rafael Aldabe; Gloria González-Aseguinolaza
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

Review 7.  HDV Pathogenesis: Unravelling Ariadne's Thread.

Authors:  Eirini D Tseligka; Sophie Clément; Francesco Negro
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

Review 8.  Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts.

Authors:  Suzanne Faure-Dupuy; Julie Lucifora; David Durantel
Journal:  Viruses       Date:  2017-04-28       Impact factor: 5.048

Review 9.  Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen.

Authors:  Florian A Lempp; Stephan Urban
Journal:  Viruses       Date:  2017-07-04       Impact factor: 5.048

Review 10.  Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease.

Authors:  Stephan Urban; Christoph Neumann-Haefelin; Pietro Lampertico
Journal:  Gut       Date:  2021-06-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.